Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$498,345,267
+$72,023,330 QoQ
Shares Held
1,962,221
+12.5% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#101
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $3,560,811,525 across 15 Drug Manufacturers - General names. JNJ ranks #2 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
876,181 | $1,050,917,864 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,962,221 | $498,345,267 | |
| 3 | ABBV |
AbbVie Inc.
|
1,561,703 | $392,986,942 | |
| 4 | AZN |
Astrazeneca PLC
|
1,978,508 | $375,164,686 | |
| 5 | NVS |
Novartis AG
|
2,386,527 | $374,016,511 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,857,628 | $367,205,197 | |
| 7 | AMGN |
Amgen Inc
|
381,869 | $138,282,402 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
954,962 | $120,649,899 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $498,345,267 | 1,962,221 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $426,321,937 | 1,744,076 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $321,239,378 | 1,552,256 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $278,989,606 | 1,504,636 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $199,642,264 | 1,306,987 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $216,129,320 | 1,303,240 | Shares | Other | 2025-05-08 | |
| 2024-12-31 | $147,822,176 | 1,022,142 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $252,167,465 | 1,556,013 | Shares | Other | 2024-11-06 | |
| 2024-06-30 | $190,176,375 | 1,301,152 | Shares | Other | 2024-08-01 | |
| 2024-03-31 | $235,259,534 | 1,487,196 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $226,550,427 | 1,445,390 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $238,130,224 | 1,528,926 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $270,205,440 | 1,632,464 | Shares | Other | 2023-08-15 | |
| 2023-03-31 | $191,634,715 | 1,236,353 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $248,249,776 | 1,405,320 | Shares | Other | 2023-01-27 | |
| 2022-09-30 | $213,492,568 | 1,306,884 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $244,876,109 | 1,379,506 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $241,256,462 | 1,361,262 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $162,255,959 | 948,477 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $140,662,462 | 870,975 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $138,858,850 | 842,897 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $126,458,285 | 769,445 | Shares | Other | 2021-05-05 | |
| 2020-12-31 | $117,986,683 | 749,693 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $110,406,578 | 741,581 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $102,758,059 | 730,698 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $114,067,757 | 869,883 | Shares | Other | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||